Medtronic plc ranks fifth among the 7 Most Promising Robotics Stocks according to Wall Street Analysts. Truist Securities maintains a Hold recommendation on MDT with a lowered price objective of $107.00. Market sentiment turned bearish with heavy put volume despite positive regulatory news. The company filed to spin off its Diabetes business as MiniMed to focus on higher-growth segments. Medtronic is a global leader in medical technology, offering innovative devices across various healthcare sectors. While MDT shows investment potential, other AI stocks may offer greater upside with less risk.

Read more at Yahoo Finance: Bearish Options Activity Emerges on Medtronic plc (MDT) Despite Long-Term Growth Outlook